搜尋
諾華
NVS添加自選
159.870USD
+5.730+3.72%
收盤 07/02, 13:00（美東）報價延遲15分鐘
305.05B總市值
22.75本益比TTM
關於 諾華 公司
諾華公司為瑞士總部的全球製藥巨頭，專注創新處方藥的研發、製造與行銷。公司現以單一 創新藥物 部門運營，聚焦免疫、腫瘤、神經、心血管、腎臟及代謝等治療領域，並運用數字平台加速臨床與商業決策。此前屬下的仿製藥與生物仿製藥業務已分拆為獨立公司 Sandoz，因此諾華資源得以全面投入先進療法與下一代技術平台。
諾華簡介
公司代碼NVS
公司名稱Novartis AG
上市日期May 07, 2001
CEONarasimhan (Vasant)
員工數量75883
證券類型Depository Receipt
年結日May 07
公司地址Lichtstrasse 35
城市BASEL
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Switzerland
郵編4056
電話41613241111
網址https://www.novartis.com/
公司代碼NVS
上市日期May 07, 2001
CEONarasimhan (Vasant)
諾華公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Patrice Bula
Mr. Patrice Bula
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
常見問題
諾華的前五大股東是誰？
諾華的前五大股東如下：Mr. Harry Kirsch
有多少機構持有諾華(NVS)的股份？
截至2026Q1，共有2164家機構持有諾華的股份，合計持有的股份價值約為143.01M，占公司總股份的7.49% 。與2025Q4相比，機構持股有所增加，增幅為-1630148.00。
哪個業務部門對諾華的收入貢獻最大？
在2026Q1，Rest of portfolio業務部門對諾華的收入貢獻最大，創收10.02B，占總收入的18.37% 。